Given its involvement in numerous pathologies, TGF-β is a target for therapeutic intervention. Inhibitors of TGF-β signaling are being explored for the treatment of fibrotic diseases and cancer. However, due to its complex role in various biological processes, therapeutic strategies need to be carefully balanced to avoid adverse effects.
